T lymphocytes, particularly CD4+ and CD8+ T lymphocytes, play a leading role in the anti-tumor function in vivo; therefore, the quantities of CD4+ and CD8+ T lymphocytes are crucial for killing the cancer cell. This evidence concerns the gene CD8A and neoplasm.